Search results
Drug said to be a breakthrough in asbestos-linked mesothelioma cancers
Scripps News via AOL· 2 months agoDr. Brad Black with the Center for Asbestos Related Disease health clinic. Researchers say they've...
Experimental drug shows promise in treating cancer linked to asbestos
United Press International via Yahoo News· 2 months agoAn experimental drug called ADI-PEG20 increased average survival of mesothelioma patients by 1.6...
£2.1m cash injection to help researchers detect asbestos cancer earlier
Press Association News via AOL· 1 year agoResearchers studying why it can take decades for exposure to asbestos to develop into a cancer...
Merck's Keytuda+Chemo Combo Improves Overall Survival In Patients With Advanced Mesothelioma
Benzinga via Yahoo Finance· 1 year agoMerck & Co Inc (NYSE: MRK) announced that the Phase 2/3 CCTG IND.227/KEYNOTE-483 trial of Keytruda...
Med student, 31, got easily winded working out. It was a sign of a ‘colossal’ tumor in his chest
TODAY via Yahoo News· 1 month agoLast year, medical student James Shen contracted COVID-19 while working in the emergency room during...
How late N.Y. Assembly Speaker Sheldon Silver used elected position to reap millions from cancer...
NY Daily News via Yahoo News· 1 year agoFormer New York Assembly Speaker Sheldon Silver died in January at age 77 while serving a 6½½-year federal prison term on bribery and money laundering charges. This excerpt from Daily News journalist ...
Is NovoCure a Good Stock to Buy Right Now?
Motley Fool· 1 year agoShares of NovoCure (NASDAQ: NVCR), a maker of niche medical devices, shot about 68% higher on Jan. 5. Investors were cheering clinical trial results for...
13 Signs Your Lungs Might Not Be Health, According to Lung Health Experts
Parade via AOL· 3 months ago13-signs-lungs-aren't-healthy-FTR Cartoon healthy lungs iStock When something is off with your...
3 Things About NovoCure That Smart Investors Know
Motley Fool· 7 months agoThe average investor might see NovoCure as yet another struggling cancer therapy company. The biggest thing that smart investors know about NovoCure is...
Adaptimmune Agrees To Merge With Another Cell Therapy Focused Company
Benzinga via Yahoo Finance· 1 year agoAdaptimmune Therapeutics plc (NASDAQ: ADAP) is merging with TCR² Therapeutics Inc (NASDAQ: TCRR) in...
